LEGEND BIOTECH CORP-ADR (LEGN) Stock Analyst Earnings Estimates
NASDAQ:LEGN - Nasdaq - US52490G1022 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 68.8M -8.27% | 117M 70.06% | 285.143M 143.71% | 631.24M 121.38% | 1.042B 65.07% | 1.569B 50.58% | 2.238B 42.64% | 2.735B 22.21% | 3.291B 20.33% | 3.589B 9.05% | 3.879B 8.08% | 4.247B 9.49% | |
| EBITDA YoY % growth | -380.1M -26.74% | -439.7M -15.68% | -507.515M -15.42% | -279.84M 44.86% | -163.905M 41.43% | 201.78M 223.11% | 237.84M 17.87% | 518.64M 118.06% | 1.024B 97.44% | 1.133B 10.64% | 1.259B 11.12% | N/A | |
| EBIT YoY % growth | -394M -27.18% | -458.1M -16.27% | -527.966M -15.25% | -306.728M 41.90% | -164.512M 46.37% | 158.69M 196.46% | 652.66M 311.28% | 877.23M 34.41% | 1.353B 54.24% | 1.539B 13.75% | 1.753B 13.91% | 1.986B 13.29% | |
| Operating Margin | -572.67% | -391.54% | -185.16% | -48.59% | -15.79% | 10.11% | 29.16% | 32.07% | 41.11% | 42.88% | 45.19% | 46.76% | |
| EPS YoY % growth | -1.35 3.39% | N/A -9.10% | -2.96 -100.97% | -1.54 48.14% | -1.08 29.57% | 0.97 189.62% | 0.93 -4.21% | 0.67 -27.47% | 2.19 225.76% | 2.82 28.37% | 3.77 33.88% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 54.74% | -0.33 -3.59% | -0.31 -211.10% | -0.26 62.50% | -0.17 52.11% | 0.16 149.23% | 0.27 185.25% | 0.37 244.00% | 0.46 364.71% |
| Revenue Q2Q % growth | 182.48M 129.64% | 199.6M 112.36% | 247.87M 32.89% | 272.34M 69.99% | 312.53M 71.27% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -94.75M 5.82% | -74.46M 33.60% | -79.56M -157.65% | -48.96M 8.98% | -28.56M 69.86% | 10.2M 113.70% | 11.22M 114.10% | 16.32M 133.33% | 25.5M 189.29% |
| EBIT Q2Q % growth | -85.546M 29.33% | -72.901M 38.15% | -45.123M -7.51% | -37.249M 47.06% | -16.211M 81.05% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.68 -100.00% | -0.45 | -0.23 | -52.09% |
| Q2 2024 Q2Q % growth | -0.10 91.23% | -0.39 | 0.29 | 74.28% |
| Q1 2024 Q2Q % growth | -0.32 52.94% | -0.35 | 0.03 | 8.88% |
| Q4 2023 Q2Q % growth | -0.80 -78.66% | -0.85 | 0.05 | 5.50% |
| Q3 2023 Q2Q % growth | -0.34 17.29% | -0.69 | 0.35 | 50.80% |
| Q2 2023 Q2Q % growth | -1.14 8.06% | -0.61 | -0.53 | -86.27% |
| Q1 2023 Q2Q % growth | -0.68 -161.54% | -0.80 | 0.12 | 14.53% |
| Q4 2022 Q2Q % growth | -49.26% | -0.45 | % | |
| Q3 2022 Q2Q % growth | 4.40% | -0.41 | % | |
| Q2 2022 Q2Q % growth | -1.24 -287.50% | -0.43 | -0.81 | -188.69% |
| Q1 2022 Q2Q % growth | -0.26 13.33% | -0.47 | 0.21 | 44.59% |
| Q4 2021 Q2Q % growth | -0.30 -36.36% | -0.42 | 0.12 | 28.26% |
| Q3 2021 Q2Q % growth | -0.43 14.00% | -0.36 | -0.07 | -18.75% |
| Q2 2021 Q2Q % growth | -0.32 74.60% | -0.34 | 0.02 | 7.04% |
| Q1 2021 Q2Q % growth | -0.30 | -0.36 | 0.06 | 15.97% |
| Q4 2020 Q2Q % growth | -0.22 | -0.29 | 0.07 | 23.87% |
| Q3 2020 Q2Q % growth | -0.50 | -0.31 | -0.19 | -59.84% |
| Q2 2020 Q2Q % growth | -1.26 | -0.27 | -0.99 | -375.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 160.205M 66.86% | 146.75M | 13.455M | 9.17% |
| Q2 2024 Q2Q % growth | 186.523M 154.36% | 129.12M | 57.403M | 44.46% |
| Q1 2024 Q2Q % growth | 93.991M 158.67% | 155.68M | -61.689M | -39.63% |
| Q4 2023 Q2Q % growth | 79.464M -32.08% | 88.08M | -8.616M | -9.78% |
| Q3 2023 Q2Q % growth | 96.013M 209.45% | 99.229M | -3.216M | -3.24% |
| Q2 2023 Q2Q % growth | 73.33M 512.61% | 55.71M | 17.62M | 31.63% |
| Q1 2023 Q2Q % growth | 36.336M -27.39% | 40.622M | -4.286M | -10.55% |
| Q4 2022 Q2Q % growth | 117.005M 548.95% | 37.221M | 79.784M | 214.35% |
| Q3 2022 Q2Q % growth | 83.81% | 31.027M | % | |
| Q2 2022 Q2Q % growth | 11.97M -40.83% | 32.325M | -20.355M | -62.97% |
| Q1 2022 Q2Q % growth | 50.04M 265.79% | 17M | 33.04M | 194.35% |
| Q4 2021 Q2Q % growth | 18.03M -55.05% | 14.51M | 3.52M | 24.26% |
| Q3 2021 Q2Q % growth | 16.88M 43.66% | 7.99M | 8.89M | 111.26% |
| Q2 2021 Q2Q % growth | 20.23M 74.40% | 9.316M | 10.914M | 117.15% |
| Q1 2021 Q2Q % growth | 13.68M 18.44% | 4.42M | 9.26M | 209.50% |
| Q4 2020 Q2Q % growth | 40.11M 80.92% | 13.26M | 26.85M | 202.49% |
| Q3 2020 Q2Q % growth | 11.75M -33.50% | 13.26M | -1.51M | -11.39% |
| Q2 2020 Q2Q % growth | 11.6M 14.97% | 13.26M | -1.66M | -12.52% |
| Q1 2020 Q2Q % growth | 11.55M 14.93% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -12.1% | -12.1% | -43.03% | -40.93% |
| Revenue | -0.95% | -0.95% | 0.15% | 5.4% |